Cassandra Pardini, PharmD

Most Recent Articles by Cassandra Pardini, PharmD

In ART-Treated HIV Patients With GI Discomfort, Consider EPI Assessment

By Nov 13, 2017

Of 100 participants, 32% had EPI (faecal elastase-1 <200 μg/g) and 20% severe EPI (faecal elastase-1 <100 μg/g).

Does Continuing Lithium Tx in CKD Patients Up the Risk of End-Stage CKD?

By Nov 10, 2017

In the subcohorts of patients with a diagnosis of bipolar disorder, continuing lithium was associated with decreased end-stage CKD, whereas continuing anticonvulsants was not.

Omega-3 Supplementation Linked to Improved Executive Functioning

By Nov 08, 2017

In children with mood disorders, Ω3 supplementation was found to decrease impairment in executive function.

Combo Treatment Assessed in Black Patients Co-Infected With HIV, HCV

By Oct 08, 2017

Retrospective chart reviews were conducted for Black, genotype 1 (GT1), HIV/HCV co-infected patients treated with ledipasvir/sofosbuvir (LDV/SOF) at 3 hospitals.

Adverse Events Examined Following PCV13 Vaccination in Children

By Oct 06, 2017

The researchers reviewed the VAERS forms and available medical records of serious reports (death, life-threatening illness, hospitalization, prolongation of hospitalization and permanent disability), and reports of Kawasaki disease and anaphylaxis.

More Articles by Cassandra Pardini, PharmD